Merck Serono - Transforming lives through medical science

Our pioneering treatments for growth hormone deficiency help both children and adults

At Merck Serono, we are actively committed to transforming lives through medical science. We specialize in the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases and other serious, life-altering diseases.

Around the world, over 17,000 employees work to discover, develop, manufacture and commercialize Merck Serono’s prescription therapies, available in over 150 countries.

We are internationally recognized as a biotechnology leader, with innovative and successful products along with a promising development pipeline. Specialized know-how in research and production means that we are able to ensure absolutely high-quality manufacturing, a key success factor especially in the biopharmaceutical industry.

In 2010, sales of Merck Serono products generated total revenues of € 5.8 billion. We devote around 20% of these earnings to the pursuit of innovative new therapies through our own research and development, strategic alliances and agreements.

The website of the division Merck Serono can be found under www.merckserono.com.

Switzerland is the home of Merck Serono’s global Headquarters as well as two major production sites. Located around Lake Geneva we are known as a leading employer in the biotech and pharmaceutical sector.

Merck Serono S.A. combines our activities performed in Geneva, Aubonne, Vevey and Coinsins under one legal roof.

Our Headquarters in Geneva hosts the Geneva Research Center as well as a number of global and support functions within the Merck Serono division. We manufacture several of our most successful drugs at Vevey and Aubonne sites, inlcuding Rebif®, Erbitux ® and Gonal-F®.

Merck Serono’s marketing, sales, regulatory and medical activities for the Swiss market are conducted in Zug at Merck (Schweiz) AG.


 
top

Select your local employer

Apply now